( The Translational Genomics Research Institute ) Combination drug therapy may be needed to combat non-small cell lung cancer, according to a study by the Translational Genomics Research Institute and Van Andel Research Institute. The study, "STAT3 is Activated by JAK2 Independent of Key Oncogenic Driver Mutation in Non-Small Cell Lung Carcinoma," was published online today, Feb. 2, 2012, by the ...